It's all in the timing

Abstract

In this issue of Blood, Ehrhardt and colleagues clearly demonstrate antagonistic effects when anthracyclins and vinca alkloids are used simultaneously.1 These findings challenge us to take a fresh look at how drugs are combined when treating patients with hematologic malignancies. (Figure Presented).